+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Flow Diversion Aneurysm Treatment Market 2020-2024 - Product Image

Global Flow Diversion Aneurysm Treatment Market 2020-2024

  • ID: 5031226
  • Report
  • May 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Acandis GmbH
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Johnson & Johnson
  • Medtronic Plc
  • MORE
Global Flow Diversion Aneurysm Treatment Market 2020-2024

The flow diversion aneurysm treatment market is poised to grow by $ 1.64 bn during 2020-2024 progressing at a CAGR of 8% during the forecast period. This report on the flow diversion aneurysm treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the preference for flow diversion aneurysm treatment and increasing prevalence of IAs and associated risk factors. In addition, improvements in the detection of UIAs is anticipated to boost the growth of the market as well.

The flow diversion aneurysm treatment market analysis includes product segment and geographic landscape.

The flow diversion aneurysm treatment market is segmented as below:

By Product
  • FDS
  • Intrasaccular flow disruption devices
By Geographic Landscape
  • North America
  • Europe
  • Asia
  • ROW
This study identifies increasing R&D focus as one of the prime reasons driving the flow diversion aneurysm treatment market growth during the next few years. Also, expanding indications and integration of advanced technologies in aneurysm treatment will lead to sizable demand in the market.

The research presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The flow diversion aneurysm treatment market covers the following areas:
  • Flow diversion aneurysm treatment market sizing
  • Flow diversion aneurysm treatment market forecast
  • Flow diversion aneurysm treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading flow diversion aneurysm treatment market vendors that include Acandis GmbH, Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., Johnson & Johnson, Medtronic Plc, MicroPort Scientific Corp., phenox GmbH, Stryker Corp., and Terumo Corp. Also, the flow diversion aneurysm treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The research presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Acandis GmbH
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Johnson & Johnson
  • Medtronic Plc
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • FDS - Market size and forecast 2019-2024
  • Intrasaccular flow disruption devices - Market size and forecast 2019-2024
  • Market opportunity by Product
Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive scenario
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Acandis GmbH
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Johnson & Johnson
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • phenox GmbH
  • Stryker Corp.
  • Terumo Corp.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Product - Market share 2019-2024 (%)
22: Comparison by Product
23: FDS - Market size and forecast 2019-2024 ($ million)
24: FDS - Year-over-year growth 2019-2024 (%)
25: Intrasaccular flow disruption devices - Market size and forecast 2019-2024 ($ million)
26: Intrasaccular flow disruption devices - Year-over-year growth 2019-2024 (%)
27: Market opportunity by Product
28: Customer landscape
29: Market share by geography 2019-2024 (%)
30: Geographic comparison
31: North America - Market size and forecast 2019-2024 ($ million)
32: North America - Year-over-year growth 2019-2024 (%)
33: Europe - Market size and forecast 2019-2024 ($ million)
34: Europe - Year-over-year growth 2019-2024 (%)
35: Asia - Market size and forecast 2019-2024 ($ million)
36: Asia - Year-over-year growth 2019-2024 (%)
37: ROW - Market size and forecast 2019-2024 ($ million)
38: ROW - Year-over-year growth 2019-2024 (%)
39: Key leading countries
40: Market opportunity by geography ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Acandis GmbH - Overview
48: Acandis GmbH - Product and service
49: Acandis GmbH - Key offerings
50: Acandis GmbH - Key customers
51: Acandis GmbH - Segment focus
52: Boston Scientific Corp. - Overview
53: Boston Scientific Corp. - Business segments
54: Boston Scientific Corp. - Key offerings
55: Boston Scientific Corp. - Key customers
56: Boston Scientific Corp. - Segment focus
57: Cardinal Health Inc. - Overview
58: Cardinal Health Inc. - Business segments
59: Cardinal Health Inc. - Key offerings
60: Cardinal Health Inc. - Key customers
61: Cardinal Health Inc. - Segment focus
62: Cook Group Inc. - Overview
63: Cook Group Inc. - Product and service
64: Cook Group Inc. - Key offerings
65: Cook Group Inc. - Key customers
66: Cook Group Inc. - Segment focus
67: Johnson & Johnson - Overview
68: Johnson & Johnson - Business segments
69: Johnson & Johnson - Key offerings
70: Johnson & Johnson - Key customers
71: Johnson & Johnson - Segment focus
72: Medtronic Plc - Overview
73: Medtronic Plc - Business segments
74: Medtronic Plc - Key offerings
75: Medtronic Plc - Key customers
76: Medtronic Plc - Segment focus
77: MicroPort Scientific Corp. - Overview
78: MicroPort Scientific Corp. - Business segments
79: MicroPort Scientific Corp. - Key offerings
80: MicroPort Scientific Corp. - Key customers
81: MicroPort Scientific Corp. - Segment focus
82: phenox GmbH - Overview
83: phenox GmbH - Product and service
84: phenox GmbH - Key offerings
85: phenox GmbH - Key customers
86: phenox GmbH - Segment focus
87: Stryker Corp. - Overview
88: Stryker Corp. - Business segments
89: Stryker Corp. - Key offerings
90: Stryker Corp. - Key customers
91: Stryker Corp. - Segment focus
92: Terumo Corp. - Overview
93: Terumo Corp. - Business segments
94: Terumo Corp. - Key offerings
95: Terumo Corp. - Key customers
96: Terumo Corp. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Acandis GmbH
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Johnson & Johnson
  • Medtronic Plc
  • MORE
The publisher recognizes the following companies as the key players in the global flow diversion aneurysm treatment market: Acandis GmbH, Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., Johnson & Johnson, Medtronic Plc, MicroPort Scientific Corp., phenox GmbH, Stryker Corp., and Terumo Corp.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing R&D focus."

According to the report, one of the major drivers for this market is the improvements in detection of UIAs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Acandis GmbH
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Johnson & Johnson
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • phenox GmbH
  • Stryker Corp.
  • Terumo Corp.
Note: Product cover images may vary from those shown
Adroll
adroll